Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jun;39(6):1386–1387. doi: 10.1128/aac.39.6.1386

In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.

M M Hayes 1, H H Foo 1, J Timenetsky 1, S C Lo 1
PMCID: PMC162749  PMID: 7574538

Abstract

In vitro susceptibilities of Mycoplasma penetrans were determined. MICs and MBCs were determined. The MICs at which 50% of the isolates are inhibited (micrograms per milliliter) for broth dilution testing were as follows: azithromycin, 0.039; chloramphenicol, 0.625; ciprofloxacin, 0.156; clindamycin, 0.078; doxycycline, 0.312; erythromycin, 0.312; gentamicin. > 10; levofloxacin, 0.078; lincomycin, 0.625; streptomycin, > 10; and tetracycline, 1.25. Bactericidal activity was significant only for ciprofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml) and levofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml).

Full Text

The Full Text of this article is available as a PDF (197.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chandler D. K., Razin S., Stephens E. B., Harasawa R., Barile M. F. Genomic and phenotypic analyses of Mycoplasma pneumoniae strains. Infect Immun. 1982 Nov;38(2):604–609. doi: 10.1128/iai.38.2.604-609.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hayes M. M., Foo H. H., Kotani H., Wear D. J., Lo S. C. In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources. Antimicrob Agents Chemother. 1993 Nov;37(11):2500–2503. doi: 10.1128/aac.37.11.2500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kenny G. E., Hooton T. M., Roberts M. C., Cartwright F. D., Hoyt J. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother. 1989 Jan;33(1):103–107. doi: 10.1128/aac.33.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lo S. C., Buchholz C. L., Wear D. J., Hohm R. C., Marty A. M. Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain). Mod Pathol. 1991 Nov;4(6):750–754. [PubMed] [Google Scholar]
  5. Lo S. C., Hayes M. M., Kotani H., Pierce P. F., Wear D. J., Newton P. B., 3rd, Tully J. G., Shih J. W. Adhesion onto and invasion into mammalian cells by mycoplasma penetrans: a newly isolated mycoplasma from patients with AIDS. Mod Pathol. 1993 May;6(3):276–280. [PubMed] [Google Scholar]
  6. Lo S. C., Hayes M. M., Tully J. G., Wang R. Y., Kotani H., Pierce P. F., Rose D. L., Shih J. W. Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS. Int J Syst Bacteriol. 1992 Jul;42(3):357–364. doi: 10.1099/00207713-42-3-357. [DOI] [PubMed] [Google Scholar]
  7. Lo S. C., Hayes M. M., Wang R. Y., Pierce P. F., Kotani H., Shih J. W. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet. 1991 Dec 7;338(8780):1415–1418. doi: 10.1016/0140-6736(91)92721-d. [DOI] [PubMed] [Google Scholar]
  8. Maiche A. G. Use of quinolones in the immunocompromised host. Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):361–367. doi: 10.1007/BF01967012. [DOI] [PubMed] [Google Scholar]
  9. Manchee R. J., Taylor-Robinson D. Studies on the nature of receptors involved in attachment of tissue culture cells to mycoplasmas. Br J Exp Pathol. 1969 Feb;50(1):66–75. [PMC free article] [PubMed] [Google Scholar]
  10. Poulin S. A., Perkins R. E., Kundsin R. B. Antibiotic susceptibilities of AIDS-associated mycoplasmas. J Clin Microbiol. 1994 Apr;32(4):1101–1103. doi: 10.1128/jcm.32.4.1101-1103.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rodvold K. A., Piscitelli S. C. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety. Clin Infect Dis. 1993 Aug;17 (Suppl 1):S192–S199. doi: 10.1093/clinids/17.supplement_1.s192. [DOI] [PubMed] [Google Scholar]
  12. Smith C. B., Friedewald W. T., Chanock R. M. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med. 1967 May 25;276(21):1172–1175. doi: 10.1056/NEJM196705252762103. [DOI] [PubMed] [Google Scholar]
  13. Ter Laak E. A., Pijpers A., Noordergraaf J. H., Schoevers E. C., Verheijden J. H. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents. Antimicrob Agents Chemother. 1991 Feb;35(2):228–233. doi: 10.1128/aac.35.2.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Waites K. B., Duffy L. B., Schmid T., Crabb D., Pate M. S., Cassell G. H. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother. 1991 Jun;35(6):1181–1185. doi: 10.1128/aac.35.6.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wang R. Y., Shih J. W., Grandinetti T., Pierce P. F., Hayes M. M., Wear D. J., Alter H. J., Lo S. C. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet. 1992 Nov 28;340(8831):1312–1316. doi: 10.1016/0140-6736(92)92493-y. [DOI] [PubMed] [Google Scholar]
  16. Wang R. Y., Shih J. W., Weiss S. H., Grandinetti T., Pierce P. F., Lange M., Alter H. J., Wear D. J., Davies C. L., Mayur R. K. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis. 1993 Oct;17(4):724–729. doi: 10.1093/clinids/17.4.724. [DOI] [PubMed] [Google Scholar]
  17. Whithear K. G., Bowtell D. D., Ghiocas E., Hughes K. L. Evaluation and use of a micro-broth dilution procedure for testing sensitivity of fermentative avian mycoplasmas to antibiotics. Avian Dis. 1983 Oct-Dec;27(4):937–949. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES